BELLUS Health Inc. (BLU) Social Stream
BELLUS Health Inc (BLU) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLU.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
BLU's average price target has moved up $7.68 over the prior 30 weeks.
BLU reports an average of 87.88% for its upside potential over the past 42 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BLU Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 62 days, BLU's average broker recommendation rating improved by 0.02.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- BELLUS Health Inc's average analyst price target is greater than 99.89% of all US stocks.
- BELLUS Health Inc's variance in analysts' estimates is lower than -591.13% of all US stocks.
- BLU has a greater number of analysts covering the stock than 730.36% of stocks in the small market cap category.
- BLU has a higher upside potential (average analyst target price relative to current price) than 272.85% of Pharmaceutical Products stocks.
What is the outlook for BLU? Use POWR Ratings for clearer insight into price direction.